Dillon Cockrell, MD· @DCockrellMD · X·· 19 hours agoScore45
Body
Great to see this data presented by @BGarmezy. Excited for this new potential treatment for men with #prostatecancer and to be part of the efforts at @DukeCancer. Appreciate your hard work and leadership @OncHahn!
#ESMO26 @AarmstrongDuke @OncoAlert @myESMO @oncodaily @OncoDailyGU @urotoday
137 views · 3 likes · 1 repost · 0 replies
Thrilled to share updated results from JNJ-6143, the AR-BRD4 RIPTAC therapy, presented by @BGarmezy. Totally novel MOA was well tolerated, oral pill and produced significant benefit for pts (PSA90 50%, ORR 68%). P2 trial active now and more coming. Lots of potential!在 X 查看被引用的帖子
Source: Dillon Cockrell, MD · x.com